Latest Research And Development News

ClearVue Technologies has achieved a key international certification for its innovative solar panels and is deepening its strategic alliance with Helios Power, setting the stage for expanded commercial deployment in the building-integrated photovoltaics market.

Papyrus Australia has commissioned its Adelaide Rapid Prototyping & R&D Facility, marking a key step in validating its pulp technology and progressing towards commercial production. The company also released its interim financials and reported stable cash flow supporting ongoing operations.

Right Resources Limited has secured over A$1.1 million in R&D-related funding, advancing its geological research and mineralisation modelling in NSW’s Tumbarumba district through a strategic partnership with the University of Tasmania’s CODES.

Temas Resources has commissioned a new metallurgical lab in Ontario to accelerate the scale-up and commercialisation of its innovative Regenerative Chloride Leach (RCL) technology, while securing initial third-party contracts to boost revenue.

State Gas Limited has decided against proceeding with the sale of its High Density Natural Gas Pilot Plant after failing to finalise terms, while its R&D tax incentive claim remains under extended review by the ATO.

Barton Gold Holdings has secured a $520,000 cash refund through the Federal Government’s R&D Tax Incentive, bolstering its exploration efforts in South Australia’s emerging gold province.

Lumos Diagnostics has secured a pivotal US FDA CLIA waiver for its FebriDx® test, vastly expanding its market reach and triggering milestone payments that bolster its US commercial rollout.

Weebit Nano has launched a significant A$80 million institutional placement, alongside additional funding initiatives, to accelerate its ReRAM technology leadership and broaden AI-related offerings.

State Gas Limited has voluntarily suspended trading on the ASX as it finalises negotiations on a significant asset sale and clarifies related R&D incentive claims. The suspension will last until an announcement expected by 30 March 2026.

Global Health Ltd reports stable revenue and a significant EBITDA improvement in H1 FY26, driven by a strategic shift to SaaS platforms and AI integration. The company’s partnership with Best Practice and upcoming Lifecard launch position it for growth in Australia’s digital healthcare sector.

Sparc Technologies has secured a $680,000 non-dilutive advance on its anticipated FY26 R&D tax refund, strengthening its cash flow as it accelerates commercialisation of its graphene additive ecosparc and green hydrogen ventures.

Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.